Difficulty: Medium
Average Score: 64%
Practice
If a patient has an INR greater than 20 and active bleeding that is clinically significant (i.e., hematuria), the pharmacist should
Correct answer
B
Rationale
The correct answer is B: If I, II, and III are correct (Hold the drug therapy, Administer vitamin K, and Administer fresh frozen plasma). When a patient has an INR greater than 20 and active bleeding, it indicates severe coagulopathy. Holding the drug therapy is crucial to prevent further exacerbation of bleeding. Administering vitamin K helps reverse the anticoagulant effects of medications like warfarin. Fresh frozen plasma provides clotting factors to help control bleeding.
Option A is incorrect because simply holding drug therapy may not be sufficient to address the severe coagulopathy and active bleeding in this critical situation.
Option C is incorrect because administering only vitamin K may not be enough to rapidly reverse the anticoagulant effects in a severe bleeding scenario.
Option D is incorrect because fresh frozen plasma alone may not adequately correct the coagulopathy induced by high INR levels, and vitamin K is also needed for effective reversal.
In an educational context, understanding the appropriate management of severe coagulopathy and active bleeding is crucial for pharmacists and healthcare professionals dealing with patients on anticoagulant therapy. This scenario highlights the importance of timely interventions to prevent life-threatening complications in patients with critical bleeding events.
Option A is incorrect because simply holding drug therapy may not be sufficient to address the severe coagulopathy and active bleeding in this critical situation.
Option C is incorrect because administering only vitamin K may not be enough to rapidly reverse the anticoagulant effects in a severe bleeding scenario.
Option D is incorrect because fresh frozen plasma alone may not adequately correct the coagulopathy induced by high INR levels, and vitamin K is also needed for effective reversal.
In an educational context, understanding the appropriate management of severe coagulopathy and active bleeding is crucial for pharmacists and healthcare professionals dealing with patients on anticoagulant therapy. This scenario highlights the importance of timely interventions to prevent life-threatening complications in patients with critical bleeding events.